ATE555787T1 - Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies - Google Patents

Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies

Info

Publication number
ATE555787T1
ATE555787T1 AT02759615T AT02759615T ATE555787T1 AT E555787 T1 ATE555787 T1 AT E555787T1 AT 02759615 T AT02759615 T AT 02759615T AT 02759615 T AT02759615 T AT 02759615T AT E555787 T1 ATE555787 T1 AT E555787T1
Authority
AT
Austria
Prior art keywords
oxygen species
reactive oxygen
treatment effects
excess reactive
cgn
Prior art date
Application number
AT02759615T
Other languages
English (en)
Inventor
Jen-Chang Hsia
Li Ma
Original Assignee
Synzyme Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synzyme Technologies Llc filed Critical Synzyme Technologies Llc
Application granted granted Critical
Publication of ATE555787T1 publication Critical patent/ATE555787T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
AT02759615T 2001-09-06 2002-09-06 Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies ATE555787T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/948,505 US20030045461A1 (en) 2001-09-06 2001-09-06 Composition and methods of esterified nitroxides gated with carboxylic acids
PCT/US2002/028761 WO2003022246A1 (en) 2001-09-06 2002-09-06 Treating effects of excessive reactive oxygen species

Publications (1)

Publication Number Publication Date
ATE555787T1 true ATE555787T1 (de) 2012-05-15

Family

ID=25487919

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759615T ATE555787T1 (de) 2001-09-06 2002-09-06 Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies

Country Status (7)

Country Link
US (5) US20030045461A1 (de)
EP (1) EP1429723B1 (de)
JP (1) JP4541699B2 (de)
CN (1) CN100430067C (de)
AT (1) ATE555787T1 (de)
AU (2) AU2002333535A1 (de)
WO (3) WO2003022217A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003247816A1 (en) * 2002-07-02 2004-01-23 Procyte Corporation Compositions containing peptide copper complexes and soft tissue fillers
CA2527522A1 (en) * 2003-05-29 2004-12-09 Kenneth Chang Methods of using nitroxides in conjunction with photosensitizers and sonosensitizers
EP1904151A4 (de) * 2005-06-22 2011-06-22 Univ Pittsburgh Notfall-erhaltungs- und wiederbelebungsmethoden
US20110027200A1 (en) * 2009-07-30 2011-02-03 Bernstein Eric F Methods to stabilize and prevent breakdown of sunscreen and other topical and oral preparations and compositions produced thereby
EP2464739B1 (de) * 2009-08-14 2016-01-13 Basf Se Verfahren in zellen- und zellfreien kulturen, zugehörige erfindungen, die bestimmte additive anwenden
US8778969B2 (en) 2009-11-07 2014-07-15 Peter H Proctor Nitrone, nitroso, and nitroxide spintraps and spin labels and their hydroxylamines
US8883409B1 (en) 2013-12-08 2014-11-11 Hemalux LLC Method of reducing pathogens in whole blood by illuminating with ultraviolet light under low oxygen conditions
CN112851571A (zh) * 2021-01-26 2021-05-28 陕西海辰风扬医药科技有限公司 2-（2，2，6，6-四甲基哌啶氮氧自由基-4-亚基）乙酸衍生物的制备方法与应用

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240797A (en) * 1977-10-18 1980-12-23 The Governing Council Of The University Of Toronto Assay for reserve bilirubin binding capacity
CH636252A5 (de) * 1978-10-20 1983-05-31 Syntech Sa Ergonomischer stuhl.
US5728714A (en) * 1985-07-18 1998-03-17 Proctor; Peter H. Method for treating hair loss using tempo
US5714482A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical spin labels and method
US5716947A (en) * 1985-07-18 1998-02-10 Proctor; Peter H. Topical doxyl composition and method
US5723502A (en) * 1985-07-18 1998-03-03 Proctor; Peter H. Topical spin trap composition and method
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
US5714510A (en) * 1985-07-18 1998-02-03 Proctor; Peter H. Topical proxyl composition and method
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
WO1988005044A1 (en) * 1986-12-29 1988-07-14 Pharmacia Ab Nitroxide compounds for the preparation of a pharmaceutical composition intended for the prophylaxis and treatment of ischemic cell damage
US5178433A (en) * 1987-06-12 1993-01-12 Frank Wagner Vehicle body mount
US5025032A (en) * 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
KR960008230B1 (ko) * 1989-10-17 1996-06-21 윌리엄 쥐.씨먼 중추신경계의 산화적 손상에 관련된 질병들을 억제하기 위한 조성물들
USRE35213E (en) * 1989-10-17 1996-04-16 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
US5622994A (en) * 1989-10-17 1997-04-22 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
DK0787492T3 (da) * 1990-03-16 2004-02-02 Us Secretary United States Dep Anvendelse af nitroxider og oxazolidiner til beskyttelse mod ioniserende stråling og oxidativt stress
US5211937A (en) 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US6002001A (en) * 1991-06-18 1999-12-14 Oklahoma Medical Research Foundation Spin trapping pharmaceutical compositions and methods for use thereof
US5338539A (en) 1992-08-04 1994-08-16 3V Inc. Benzofuran derivatives useful as sunscreens
FR2695560B1 (fr) 1992-09-17 1994-11-04 Oreal Composition cosmétique filtrante photostable contenant un filtre UV-A et un polymère filtre du type silicone benzotriazole.
US5362481A (en) 1993-03-05 1994-11-08 3V Inc. Benzofuran derivatives and the use thereof as stabilizers against UV radiations
US5741893A (en) * 1993-08-16 1998-04-21 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
TW381022B (en) * 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5817632A (en) * 1993-08-16 1998-10-06 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5804561A (en) * 1993-08-16 1998-09-08 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5824781A (en) * 1993-08-16 1998-10-20 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5767089A (en) * 1993-08-16 1998-06-16 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5725839A (en) * 1993-08-16 1998-03-10 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
US5807831A (en) * 1993-08-16 1998-09-15 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5840701A (en) * 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
FR2714604B1 (fr) * 1993-12-30 1996-01-26 Oreal Utilisation d'un accepteur de spin dans une composition cosmétique ou dermatologique.
US5601811A (en) 1994-08-01 1997-02-11 Croda, Inc. Substantive water-soluble cationic UV-absorbing compounds
ATE212536T1 (de) 1994-10-14 2002-02-15 Hoffmann La Roche Lichtstabile kosmetische sonnenschutzmittel
WO1996015110A1 (en) * 1994-11-15 1996-05-23 Moreno Paolini N-hydroxypiperidines as superoxide radicals scavengers
US5518713A (en) 1995-02-13 1996-05-21 3V Inc. Benzoxazole derivatives, the use thereof as sunscreens and cosmetic compositions containing them
WO1997000851A1 (en) 1995-06-23 1997-01-09 Zylepsis Limited Chemical compounds and methods of production thereof
JP3155685B2 (ja) * 1995-07-20 2001-04-16 財団法人山形県企業振興公社 ペルオキシダーゼの測定方法
DE69726144T9 (de) * 1996-05-07 2004-09-09 Bernstein, Eric F. Topische verwendung von tempol zur vorbeugung der lichtalterung
US5840734A (en) * 1997-05-06 1998-11-24 Thomas Jefferson University Use of tempol in the prevention of photoaging
WO1999000365A1 (fr) * 1997-06-27 1999-01-07 Daiichi Radioisotope Laboratories, Ltd. Nouveaux composes nitroxyle, et medicaments et reactifs contenant ceux-ci en tant que principe actif
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6017315A (en) * 1998-02-25 2000-01-25 Respironics, Inc. Patient monitor and method of using same
US6197826B1 (en) * 1998-07-17 2001-03-06 Centaur Pharmaceuticals, Inc. α-(2-hydroxyphenyl) nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation
UA66401C2 (en) * 1998-12-02 2004-05-17 Sentor Pharmaceuticals Inc 3,4,5-trisubstituted aryl nitrone compounds and pharmaceutical composition containing the same
US6235931B1 (en) * 1998-12-30 2001-05-22 Shell Oil Company Partial oxidation of polyoxyalkylene polyol compositions to polycarboxylic acid compositions
FR2791979B1 (fr) * 1999-04-08 2003-05-16 Atochem Elf Sa Procede de preparation d'alcoxyamines a partir de nitroxydes
US6552040B1 (en) * 1999-06-23 2003-04-22 Eric F. Bernstein Use of nitroxides in wound healing and in the prevention of photodamage
KR20050033512A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 펩타이드 구리 착물 및 레티놀, 레티놀 유도체 또는이들의 혼합물을 함유하는 피부 보호 조성물

Also Published As

Publication number Publication date
EP1429723A4 (de) 2005-06-15
US20030045461A1 (en) 2003-03-06
US20030092764A1 (en) 2003-05-15
WO2003022217A9 (en) 2004-04-15
EP1429723A1 (de) 2004-06-23
AU2002333536A1 (en) 2003-03-24
EP1429723B1 (de) 2012-05-02
US20070092540A1 (en) 2007-04-26
CN1553797A (zh) 2004-12-08
CN100430067C (zh) 2008-11-05
US7229629B2 (en) 2007-06-12
US7314633B2 (en) 2008-01-01
JP4541699B2 (ja) 2010-09-08
US20030113278A1 (en) 2003-06-19
US20030078241A1 (en) 2003-04-24
AU2002333535A1 (en) 2003-03-24
JP2005505556A (ja) 2005-02-24
WO2003022218A2 (en) 2003-03-20
WO2003022217A3 (en) 2003-12-04
WO2003022218A3 (en) 2003-10-16
WO2003022246A1 (en) 2003-03-20
WO2003022217A2 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
DK0832081T3 (da) Bicykliske-aromatiske forbindelser
ATE322878T1 (de) Biotin enthaltende galenische formulierung
NZ328874A (en) Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
BG106155A (en) Novel derivatives and analogues of galanthamin
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
ATE555787T1 (de) Behandlungseffekte von überschüssigen reaktiven sauerstoffspezies
DE59909607D1 (de) Tan-1057 derivate
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
NO20006337L (no) Diarylselenidforbindelser og deres anvendelse i human- eller veterinærmedisin og i kosmetikk
DE69314586T2 (de) Arzneimittelzusammensetzung enthaltend TCF-II
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto
BR0016646A (pt) Método para tratar um paciente que sofre de dor, e, composição farmacêutica
MXPA04005265A (es) Uso de derivados del acido 4-oxobutanoico para el tratamiento contra inflamacion.